2nd study also shows significant drop in virus cases among newly vaccinated

A study by the Maccabi health provider finds a steep drop in coronavirus infections among those who received the first dose of the Pfizer-BioNTech vaccine, from 13 days onward.

The survey of over 400,000 Maccabi members finds the number of cases dips by 60 percent, from 13 days after the administration of the first dose, according to Channel 12.

The study comes as another health provider, Clalit, records a 33% drop from the 14th day.

Illustrative: A Sheba Medical Center staff member receives the second round of a COVID-19 vaccine, at the hospital in Ramat Gan, on January 10, 2021 (Miriam Alster/Flash90)

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.